SGLT2 inhibitors have been shown to significantly reduce NT-proBNP levels in patients with chronic HF, but their effect on BNP did not reach statistical significance due to high heterogeneity in study results [ 117 ].
← all excerpts
Saudi Heart Association Position Statement on NT-proBNP for Cardiovascular Risk Screening in Asymptomatic Adults With Type 2 Diabetes Mellitus.
1
—
—